Chester County News and Community Website
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) said the U.S. Food and Drug Administration has accepted for review its biologics license application for MOLBREEVI as a treatment for autoimmune pulmonary …
Savara’s MOLBREEVI BLA Receives FDA Priority Review Read More
QUAKERTOWN, PA — DEXIS™ announced the launch of IS Connect Cloud for Labs and expanded software integrations aimed at strengthening digital collaboration between dental laboratories and clinics.
DEXIS Launches Cloud Platform for Lab-to-Clinic Workflows Read More
NEWTOWN, PA — EPAM Systems, Inc. (NYSE: EPAM) reported fourth-quarter 2025 revenue of $1.408 billion, up 12.8% from a year earlier, and full-year revenue of $5.457 billion, up 15.4%, the …
EPAM Systems Reports Fourth Quarter and Full-Year 2025 Results Read More NEWTOWN, PA — EPAM Systems Inc. (NYSE: EPAM) announced the North American launch of Empathy Lab, an AI-focused marketing agency designed to help brands integrate data, technology and creative strategy …
EPAM Launches Empathy Lab in North America Read More
QUAKERTOWN, PA & LIMERICK, PA — QNB Corp. (OTCQX: QNBC) and The Victory Bancorp, Inc. (OTCQX: VTYB) announced that shareholders of both companies have approved their previously announced merger transaction.
QNB Corp, Victory Bancorp Shareholders Approve Merger Read More
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) announced that company management will participate in two upcoming institutional investor conferences in March, including live presentations and one-on-one meetings …
Orchestra BioMed to Present at Two Healthcare Conferences Read More
NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) announced completion of a 90-patient Phase 2 study evaluating its investigational COVID-19 treatment ratutrelvir against PAXLOVID® and provided an update on development …
Traws Pharma Reports Phase 2 COVID-19 Data, Flu Program Update Read More
DOYLESTOWN, PA — Aprea Therapeutics Inc. (Nasdaq: APRE) reported additional preliminary data from its ongoing Phase 1 ACESOT-1051 trial showing a second unconfirmed partial response in a patient with advanced …
Aprea Reports Second Partial Response in Phase 1 APR-1051 Trial Read More DOYLESTOWN, PA — Aprea Therapeutics Inc. (Nasdaq: APRE) said its president and chief executive officer, Oren Gilad, will provide a corporate update at the Oppenheimer 36th Annual Healthcare Life Sciences …
Aprea to Present at Oppenheimer Healthcare Conference Read More LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) granted stock options and restricted stock units covering a total of 15,000 shares to a newly hired employee on February 10, 2026, the …
Savara Grants Inducement Equity Awards to New Employee Read More